Skip to content
Rachel Smith

Rachel Smith Facebook ad: “The Gastroenterologist Broke Ranks”

Rachel Smith Facebook ad: The Gastroenterologist Broke Ranks

Ran for 1 day, from October 13 to October 14, 2026, the last day Crush saw it.

Run by Rachel Smith on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Make your own version of this ad

Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.

About this ad

Meta Ad Library ID
1108512224923759
Platforms
Facebook, Instagram, Audience Network, WhatsApp and Threads
Relaunches
2

How we count

Ad text

I've been a gastroenterologist for 26 years, and if your bloating keeps spreading, your IBS keeps "flaring," your rifaximin stops working after six weeks, and nobody in GI has ever once mentioned the word mold to you — I'm about to tell you exactly why it's getting WORSE and why the GI industry will NEVER tell you the truth. And by the end of this, you're gonna be pissed. My name is Dr. Rowan Kessler. Board-certified gastroenterologist. Twenty-six years in functional GI disorders, IBS, and chronic bloating. Published in Gastroenterology and the American Journal of Gastroenterology. Over 9,400 patients. And I'm breaking ranks with my own profession to tell you this. Because there are three things happening right now: One — The swelling in your abdomen is not "IBS flaring." Your gut lining is being actively inflamed by a biofilm-protected mold mycotoxin reservoir in your intestinal mucosa — and every month you don't dissolve that shield, the overgrowth under it refills, the inflammation deepens, and the bloating recruits new triggers until you can barely eat Two — The rifaximin, the elimination diets, the Atrantil, the functional medicine stacks, and the FODMAP protocols you've been prescribed were never capable of reaching that shield, and your gastroenterologist knows it Three — There's a multi-billion-dollar functional GI industry that profits every single time your bloating "flares back" after another "clean" scope So let me tell you what happened with one of my patients, because her story is gonna open your eyes to how messed up this really is. Her name was Claire. 43 years old. For YEARS, and I mean like five straight years, she was dealing with this. Her symptoms? It started with bloating by 10 AM every day. Flat stomach at breakfast, three-inch increase in abdominal circumference by lunch. She came to me early — eight months in. I told her we'd handle it. No big deal. I ran a basic workup. Celiac panel negative. H. pylori negative. Basic metabolic normal. I ran a SIBO breath test. Positive, methane-dominant. "That's your answer," I told her. I prescribed rifaximin, two weeks, 550 milligrams three times a day. She trusted me. She took every dose. She waited. The bloating got maybe 25% better during the course. Came roaring back within five weeks. And then it jumped. I ran a second rifaximin round. Same result. Added neomycin for the methane. Same result. The bloating that had started as a 10 AM event became an all-day event. Then she started reacting to foods that had never bothered her: raw vegetables, onions, garlic, apples, pears, cauliflower, beans. Then she started getting cramping after every meal. Then she started getting diarrhea on days she had been fine the week before. Then constipation on alternating days. Then nausea at 3 PM every afternoon. Then a 20-pound weight gain despite eating less food than she had ever eaten in her life. By the end of year two, Claire had chronic daily bloating, abdominal distension severe enough that strangers asked when she was due, cramping after every meal, alternating diarrhea and constipation, afternoon nausea, 20 pounds of inflammation weight she could not lose, and a food list she could tolerate that had shrunk from everything-she-wanted to chicken-rice-and-sweet-potato. And the pattern was still spreading. She stopped going to dinners. Stopped eating with her family at the kitchen table. Started eating alone at 5 PM so her husband would not see her unbutton her pants after she ate. She told me once: "I plan my entire life around what I think my stomach will tolerate and I am always wrong." And the fear? It wasn't just discomfort anymore. She was terrified she had something I was missing. She had a sister who had been diagnosed with ovarian cancer at 46 after a year of "bloating that was probably IBS" and Claire was now 43 and she was watching her abdomen distend every afternoon and wondering if we were about to find a mass on the scope I kept telling her she did not need yet. And here's what makes me sick to my stomach: I was the doctor she trusted. Multiple visits. Year after year. We're talking thousands of dollars in copays, breath tests, endoscopies, colonoscopies, GI MAPs, the full workup playbook. And you know what I kept telling her? "The rifaximin needs more time to work." "Let's try another round." "IBS can take years to stabilize. We just need the right combination." "Have you been strict with the low-FODMAP?" HAVE YOU BEEN STRICT WITH THE LOW-FODMAP. This woman had been eating chicken, rice, and sweet potato for eighteen months. She had lost her social life to a protocol. She had been strict enough that she had lost nine pounds of lean mass. And I was asking her if she was being strict enough. But here's where it gets worse — and this is the part that haunts me now. I ran a second SIBO breath test when the first round failed. Positive. I ran an endoscopy. Mild gastritis, nothing structural. I ran a colonoscopy. Normal. I added prokinetics between meals. I referred her to a GI dietitian who put her on a strict low-FODMAP protocol for twelve weeks, then low-FODMAP plus low-histamine for twelve more. I ran a second colonoscopy at year four because her symptoms kept worsening. Still normal. I ran a repeat endoscopy with duodenal biopsies for microscopic inflammation. Mild duodenal inflammation that I called "nonspecific." I added a trial of mesalamine. I referred her to a functional medicine gastroenterologist colleague who ran an $890 GI MAP and started her on a $340-a-month stack: binders, Atrantil at every meal, berberine, oregano capsules at bedtime, a proprietary probiotic. You know what happened? The symptoms kept spreading. The second rifaximin course did nothing. The neomycin gave her a two-week low. The prokinetic sedated her. The low-FODMAP protocol worked at month three and stopped working at month six. The low-FODMAP plus low-histamine stripped her diet to twelve safe foods. The mesalamine did nothing. The GI MAP showed overgrowth of three bacterial species, elevated zonulin, low secretory IgA. The functional medicine stack brutalized her for six weeks of "die-off" and gave her maybe 20% improvement that held for three months and faded. I watched this woman — who did everything I told her, spent over $18,000 across five years on GI workups and medications and a functional medicine stack, followed every protocol — get WORSE. Not better. Worse. And I didn't understand why. Until a 61-year-old GI microbiome and biofilm biologist taught me more about chronic bloating and IBS in women in 20 minutes than I learned in nearly three decades of gastroenterology training. October 2024. Chicago. The American College of Gastroenterology Annual Scientific Meeting. I was wearing a loose dress because my own abdominal circumference had been climbing for a year. Because at 53, my own body had broken sixteen months earlier. Bloating by 10 AM every single day. Flat at breakfast, four inches larger at lunch. Cramping after every meal. The same patient history I had been seeing in my chair for 26 years was now mine. My SIBO breath test had been positive. I had done two rounds of rifaximin on myself. The second round did nothing. I had been self-prescribing prokinetics. And new symptoms had been creeping in for a year: fog, 3am wake-ups, puffy face, a resting pulse that climbed when I lay flat, hives after wine. I had blamed perimenopause. That's when I saw her. Dr. Beatrix Sommerfeld. 61 years old. GI microbiome and biofilm biologist who had moved her lab from a university in Vienna to a research institute in Washington State to focus full-time on biofilm-protected mold mycotoxin dysbiosis in women labeled with IBS and functional bloating. She was giving a late-afternoon session on mold mycotoxin reservoirs in the intestinal mucosa and the correlation with recurrent SIBO and refractory IBS. The room was a third full. Most of my colleagues had gone to the newest biologic trial talks for IBD across the hall. After her session I walked up to the podium. "Dr. Sommerfeld — I'm a GI with 26 years of practice. My own rifaximin stopped working. My scopes are clean. I think I'm missing something." She smiled. The kind of smile that knows something you don't. Then she asked how I was feeling in my body generally. And I — a gastroenterologist whose own gut had been rebelling for a year — told her about the fog, the 3am wake-ups, the puffy face, the hives from wine, the climbing pulse. Symptoms I had been telling myself were perimenopause. Her face changed. And what she said next made my stomach drop. "Dr. Kessler, those are not perimenopause symptoms. Those are mold mycotoxin symptoms. And the reason your rifaximin is failing and your scopes are clean is because the overgrowth driving your bloating is not just bacterial. It is biofilm-protected. The ochratoxin A, gliotoxin, and trichothecenes in your intestinal mucosa hide inside a biofilm — a lipid shield — that protects a mold-driven dysbiosis your rifaximin cannot reach and your scope cannot see. The scope visualizes the lumen. The shield lives in the mucosa behind it." She looked at me seriously. "Every month you spend on rifaximin, low-FODMAP, and binder stacks is another month you are managing the free-floating bacteria while a biofilm-protected mold reservoir in the mucosa keeps releasing mycotoxins into the gut lining and reseeding the overgrowth. The rifaximin kills what is in the lumen. The reservoir keeps repopulating the lumen. That is why every single round works for six weeks and then stops." I felt sick. Then she said: "The problem isn't your workup. It's your delivery system. You are trying to drain a sink with the tap left on and the drain blocked." She gestured to an empty table. "May I show you something? It will take twenty minutes. But it will change how you understand this completely." What she taught me in 20 minutes changed everything. She drew a simple diagram on a napkin. "Your treatment model treats IBS and functional bloating as either a bacterial overgrowth problem or a motility problem or a FODMAP sensitivity problem. So you prescribe rifaximin for the bacteria. Prokinetics for the motility. Elimination diets for the sensitivity. That's like draining a sink with the tap left on and the drain blocked. The water drops for a minute. The sink refills within the hour." She tapped the napkin. "This isn't a bacterial problem. It isn't a motility problem. It isn't a FODMAP problem. It is a mold biofilm problem driven by a mycotoxin reservoir in your intestinal mucosa. The mold mycotoxins hide inside a lipid shield embedded in the mucosal lining. That shield protects a dysbiotic microbiome underneath it. The shield recirculates its contents through the enterohepatic loop every meal, every day, replenishing the reservoir at the mucosal level every single day. Your rifaximin kills the bacteria that briefly show up in the lumen when the shield releases its contents. Then the shield releases more. Then the overgrowth repopulates. That is why your bloating returns in six weeks like clockwork." Now pause for a second. You know what's insane? We learned in GI fellowship that bacterial biofilms exist in the gut. We learned that mycotoxin exposure impacts intestinal permeability. We learned that mold-driven dysbiosis has been documented in the environmental medicine literature for over a decade. We KNOW this. It's in the papers. And yet we keep running SIBO breath test after SIBO breath test and prescribing rifaximin round after rifaximin round and ordering elimination diet after elimination diet in women whose entire bloating pattern is being driven by a mold reservoir no GI workup is going to catch. And that's not an accident. Because once you understand that rifaximin cannot touch the biofilm, you realize why Claire's bloating kept spreading. Why MY abdominal circumference kept climbing. Why the pattern moves from 10 AM bloating to all-day bloating to cramping to nausea to a shrinking food list while you do round after round after round. Here's what's actually happening underneath: Your intestinal mucosa contains a reservoir of mold mycotoxins bound inside a biofilm shield. The lipid wax sits over the mucosal lining and protects a dysbiotic microbiome underneath. The water-based medications you take orally cannot penetrate it. Rifaximin kills free-floating bacteria in the lumen. The shield releases new overgrowth into the lumen as fast as the rifaximin kills it. The low-FODMAP protocol starves the free-floating bacteria of substrate temporarily. The reservoir keeps releasing. The binders bind what is already loose in the lumen. The shield keeps releasing more. The prokinetic moves things through faster. The reservoir refills behind it. Every mycotoxin released from the shield inflames the mucosa directly. That inflammation increases intestinal permeability, raises zonulin, lowers secretory IgA, and recruits more immune activity into the gut lining. The gut becomes more reactive to foods it tolerated before, which is why your safe-food list keeps shrinking. The histamine load from mast cell activity in the inflamed mucosa drives the afternoon flushing, the headaches, the nausea. The second you stop any protocol? The reservoir floods the lumen unchecked and the next week of symptoms is worse than the baseline you started from. The result? A relentless, measurable progression that your GI calls "refractory IBS" or "chronic recurrent SIBO" and that is in fact the natural history of a biofilm-protected mold reservoir no one has looked for. So the bloating doesn't just persist. It EXPANDS into cramping, nausea, dietary intolerance, and systemic symptoms. Actively. While you watch. And here's the key thing I learned: Rifaximin, elimination diets, prokinetics, and binder stacks don't work for a mold mycotoxin reservoir that lives behind a lipid shield embedded in the intestinal mucosa. GI drugs are designed for bacterial overgrowth in the lumen and motility problems and food sensitivities. A chronic biofilm-protected mold reservoir in the mucosa? The drugs never reach the mechanism driving the dysbiosis. But Claire's lumen wasn't the problem. MY lumen wasn't the problem. The problem was that the reservoir was in the MUCOSA, behind a SHIELD, and the free-floating bacteria that rifaximin killed every six weeks were a downstream symptom of the mold reservoir repopulating the gut from the inside of the lining. So the rifaximin killed the bacteria in the lumen. The low-FODMAP starved them. The binders bound them. The prokinetic moved them through. The functional medicine stack brutalized them. And the mold reservoir kept releasing. And the overgrowth kept repopulating. And the bloating kept spreading. Because it's not an SIBO problem. It's a SHIELD problem. And here's the part that made my blood boil: The GI industry KNOWS about intestinal biofilms. We know about mycotoxin-driven dysbiosis in the environmental medicine literature. Researchers publish papers on biofilm-protected gut overgrowth. But we keep running SIBO breath tests and prescribing rifaximin because that's what the specialty is built on and that's what insurance pays for. Why? Because the GI industry does not make money dissolving mold biofilm shields in the intestinal mucosa. It makes money per breath test, per endoscopy, per colonoscopy, per GI MAP, per office visit for medication titration, per rifaximin prescription. You cannot bill ten thousand dollars for a dropper of NAC and liposomal glutathione. There's no money in telling a chronic bloating patient that her reservoir is behind a lipid shield in the mucosa and her SIBO is going to keep recurring every six weeks while her food list shrinks. There IS money in selling her $800 breath tests twice a year, $3,500 scopes every two years, $890 GI MAPs, $700 rifaximin prescriptions four times a year, and $400 office visits every six to eight weeks for the rest of her life. See how that works? Beatrix showed me the actual PROTOCOL for dissolving the biofilm shield and letting the intestinal mucosa recover from the inside. It involves five specific things happening simultaneously: 1. Shield dissolution — A compound that enters the bloodstream and dissolves the lipid biofilm shield in the intestinal mucosa. NAC is sulfur-containing and lipid-active. It merges with the shield and dissolves it on contact. NAC has independent documented effects on gut biofilm disruption in the microbiology literature. 2. Real-time neutralization — As the shield dissolves and mold mycotoxins are exposed, they must be neutralized before they can reinflame the mucosa or recirculate through the enterohepatic loop. Liposomal glutathione, delivered sublingually, reaches tissue at ten to twenty times the concentration of a capsule and neutralizes mycotoxins the moment they are released. 3. Liver protection — Milk thistle protects the hepatocytes doing the conjugation work so the clearance pipeline doesn't collapse under the load. 4. Bile pathway opening — TUDCA opens the bile duct so the conjugated load actually exits the body instead of recirculating through the enterohepatic loop. Interrupts the mold mycotoxin loop that reseeds the intestinal mucosa every meal. TUDCA has additional documented benefits for bile acid signaling and gut lining recovery. 5. Final binding and excretion — Fulvic and humic acid bind what's been loosened in the gut lumen and carry it out so none of it gets reabsorbed. There are actual peer-reviewed studies showing that NAC disrupts intestinal biofilms, that sublingual liposomal glutathione reaches tissue at clinical concentration, that TUDCA opens bile flow and interrupts the enterohepatic loop and supports gut barrier recovery, and that fulvic and humic acid bind mycotoxins in the intestinal lumen. The GI biofilm literature has documented that resolving mucosal mycotoxin reservoirs produces measurable reductions in bloating, zonulin, and food reactivity. Nature already built the protocol. We just stopped paying attention when the GI pharmacology industry offered something more profitable per round. But you'll never hear most gastroenterologists mention it. Because supplement companies don't make properly formulated sublingual liposomal five-compound protocols for GI. They make probiotics and generic digestive enzymes. So that's what we're trained to begrudgingly tolerate as the "lifestyle" piece around our billable workups. The financial model is backwards. A patient on rifaximin rotations plus scopes plus GI MAPs plus office visits plus functional medicine stacks pays $300 to $600 monthly on average, with periodic $3,500 scope and $890 GI MAP events. Average lifetime GI spend for a woman labeled with "refractory IBS" or "chronic recurrent SIBO": $30,000 to $100,000. A sublingual five-compound protocol that dissolves the shield? No recurring GI revenue. The system isn't designed to resolve the mechanism. It's designed to run round after round while the shield keeps feeding the overgrowth. Now here's the problem I ran into... Most "gut biofilm supplements" on the market are garbage. I tried an oregano oil capsule. Standard enteric-coated version. Did maybe 10% at best. I tried a monolaurin biofilm disruptor. Did nothing for the bloating. I tried a cheap NAC capsule, 600 milligrams. Oral absorption was too poor and nothing reached the mucosa where the shield lives. I tried a glutathione capsule marketed to IBS patients. Just reduced glutathione in a vegetable capsule. Destroyed by stomach acid before it hit circulation. I tested fourteen different products after Chicago. Spent over $700 total on capsules and powders that were either poorly delivered, too weak, or missing most of the protocol. Because here's the thing: A generic NAC capsule is NOT the same as a sublingual five-compound biofilm-dissolution protocol for intestinal mucosa. Most supplements use low-grade NAC with poor oral bioavailability and no delivery mechanism to reach mucosal tissue. It's like trying to drain a sink with a teaspoon while the tap stays on. Wrong vehicle, wrong target. True shield dissolution in the mucosa requires NAC at a therapeutic dose combined with true liposomal glutathione delivered sublingually where it bypasses the stomach entirely and reaches tissue at clinical concentration. Combined with milk thistle, TUDCA, and fulvic and humic acid to complete the clearance pipeline so what you release actually leaves the body instead of recirculating back into the mucosa. Every supplement I tested failed at least one of the five requirements. Until I found Cerise. They had a Mold Clearance Support formula. Not a probiotic. Not a generic biofilm capsule. An actual sublingual liposomal five-compound protocol. With ALL FIVE requirements. NAC to dissolve the biofilm shield in the mucosa. True liposomal glutathione for real-time neutralization at tissue concentration. Milk thistle for hepatocyte protection. TUDCA to open the bile, break the recirculation loop, and support gut lining recovery. Fulvic and humic acid for final binding and excretion. Sublingual delivery that bypasses stomach acid and gets the compounds into the bloodstream through the mucous membrane under the tongue. When I dug into the formulation? It was based on the exact compounds studied in peer-reviewed GI biofilm and mycotoxin research. The same mechanisms that scientists have documented for mucosal shield dissolution and gut lining recovery. The same approach that European integrative gastroenterologists have used for over a decade with women their GI clinics had written off as refractory IBS or chronic recurrent SIBO. They weren't just selling a supplement. They understood the science. They knew WHY the SIBO keeps recurring while the scopes stay clean. They built something to actually dissolve the shield feeding the overgrowth. And here's where I had to face what I'd done to my patients: When Claire was being treated by me? $400 office visits every six to eight weeks. Multiple $800 breath tests. Two $3,500 scopes. Multiple rifaximin courses at $700 each. Neomycin. Prokinetics. Then the referral to the functional medicine GI, who ran the $890 GI MAP and put her on a $340-a-month stack she stayed on for sixteen months. She had spent over $18,000 across five years on GI treatment that failed her. The Cerise drops? $59 per bottle. A rounding error against what she'd been spending. Uses the actual biofilm-dissolution protocol in the intestinal mucosa. NAC that enters the bloodstream and dissolves the shield in the mucosal lining. Sublingual liposomal glutathione that reaches tissue at clinical concentration. TUDCA that interrupts the recirculation loop so the mold mycotoxins actually leave. Two milliliters under the tongue in the morning. Thirty seconds. Done. I started using them myself first. Week 2: The 10 AM bloating — that relentless, button-pops-at-11-every-day pattern I'd stopped expecting to change because it had become my normal — began shortening. By day eleven my waistband sat flat at the same tightness from breakfast until mid-afternoon for the first time in a year. The shield was being dissolved from the inside for the first time. Week 4: My own ochratoxin A, which I had secretly ordered after the conference, had been 10.1. Repeat at week 4 came back at 4.3. Gliotoxin had been 3.9. Came back at 1.4. My body was moving numbers for the first time in sixteen months. The afternoon nausea was gone. The puffy around my jaw was softening. Week 8: The bloating was gone. Not improved. Gone. I ate a bowl of pasta with my husband on a Friday night, including garlic, including a glass of wine, including a dinner roll. I measured my waist before bed. Same number it had been at breakfast. First time in two years. The cramping was gone. The afternoon nausea was gone. The food reactions were gone. I ate raw broccoli at lunch the next week and nothing happened. The hives from wine were gone. The spread had stopped. No new symptoms. Week 12: Full repeat panel. Ochratoxin at 1.0. Gliotoxin at 0.3. CRP normalized. I repeated my own breath test out of curiosity. Negative. No methane peak. My zonulin, which I had quietly run on myself at the start, had dropped from elevated to within normal range. The shield had been dissolved. The reservoir was clearing. My mucosa was no longer being inflamed. Then I called Claire. And every other patient I'd failed. "I need to tell you something. The workups I ran on you were missing a piece. The rifaximin was never going to resolve this. There was a mold reservoir in your intestinal mucosa that no breath test was ever going to catch, no scope was ever going to see, and no round of rifaximin I prescribed was ever going to touch. I didn't know. I do now." Claire ran the protocol for sixteen weeks. Her ochratoxin A dropped from 11.2 to 1.3. Her gliotoxin from 4.5 to 0.4. Her bloating resolved by week six. Her food list expanded from twelve safe foods back to a normal diet by week ten. Her 20 pounds of inflammation weight came off by week fourteen without any additional dietary change. Her repeat breath test at month four came back negative for both hydrogen and methane. Her repeat GI MAP showed all three overgrowth species back in normal range, zonulin normalized, secretory IgA back up. Her functional medicine gastroenterologist colleague called her office and asked for the bottle name. Before: Daily all-day bloating, cramping after every meal, alternating diarrhea and constipation, afternoon nausea, 20 pounds of inflammation weight, 12-food safe list, positive SIBO, elevated zonulin, low secretory IgA. After 16 weeks on protocol: No bloating. Normal digestion. Normal weight. Normal diet. Negative SIBO. Normal GI MAP. Cost of GI treatment that failed her: over $18,000 across five years. Cost of what worked: a fraction of a single breath test. She hosted Thanksgiving dinner for her entire family last month. First time in four years. She ate everything on the table. She wore the dress she had put away in year two of her symptoms. Her sister looked at her across the table and asked when she had lost the weight. Claire told her she had not been dieting. She had been clearing the shield. Her sister, who had been through her own ovarian cancer treatment three years earlier, started crying. The spreading? Stopped. She ate garlic bread with her husband at an Italian restaurant on Monday night. First time in three years. No bloating. No cramping. No shame. She got her life back. This is the protocol they don't want you to know about. Because the second you dissolve the biofilm shield from the inside, the mucosa stops being inflamed, the overgrowth stops repopulating from behind the shield, and the SIBO your rifaximin kept kicking down the road finally has nowhere to recur from. You don't need their fifth round of rifaximin anymore. You don't need their third repeat colonoscopy to confirm nothing structural is wrong while your bloating keeps spreading. Your gut lining starts HEALING from the inside out. Now here's what I need you to understand about timing: The urgency Beatrix warned me about is real. The reservoir doesn't wait. Every month the shield stays intact and the mold mycotoxins keep inflaming the mucosa, the overgrowth under the shield gets more entrenched, the intestinal permeability deepens, the food reactivity expands, and the symptom pattern recruits new domains. 10 AM bloating becomes all-day bloating. All-day bloating becomes cramping plus nausea. Cramping plus nausea becomes a 12-food safe list. A 12-food safe list becomes malnutrition. I've watched the pattern unfold in over 100 patients. I watched it unfold in Claire. I watched it unfold in my own gut. If you're at 10 AM bloating and nothing else yet — you have a chance to dissolve the shield before the pattern spreads. Every month matters. If you're already dealing with bloating plus cramping plus food reactivity plus a shrinking safe list — the reservoir has been inflaming your mucosa the entire time. You can still dissolve the shield. But the permeability and reactivity get harder to reverse the longer the shield stays intact. If you're reading this and your GI has already suggested a third colonoscopy or a fourth rifaximin round or has mentioned biologics for presumed microscopic IBD — act now. Those interventions are built on a model that was never the mechanism driving your symptoms. If you're someone who's been dealing with this — chronic bloating, recurrent SIBO, a shrinking safe-food list, scopes that keep coming back clean, a GI MAP that shows dysbiosis your protocols cannot resolve — and nothing has worked? It's not because your IBS is "refractory." It's not because you aren't being strict with the FODMAPs. It's because the reservoir is a mold biofilm in your mucosa and every protocol you've been prescribed was managing what was already in the lumen while the shield kept releasing new overgrowth from inside the lining. Draining a sink with the tap left on. Cerise has a 90-day money-back guarantee — if it doesn't work, you're not out anything. And honestly? Even if you're skeptical, try it for 90 days. See if your bloating resolves. See if your safe-food list expands. See if your SIBO stops recurring. That's your proof. Because the GI industry isn't coming to save you. We profit too much per breath test, per scope, per rifaximin round to go looking for a protocol that could resolve the mechanism between workups. A 61-year-old GI microbiome and biofilm biologist taught me more in 20 minutes than I learned in nearly three decades of gastroenterology training. It's about time I passed that lesson on. Go get it. https://trycerise.com/pages/cerise-lp3 P.S. — I still run breath tests and scopes — but only after I have screened for a mucosal mold reservoir and, where indicated, run the shield-dissolution protocol first. For "refractory IBS" and "chronic recurrent SIBO" driven by a biofilm-protected mold reservoir, no amount of rifaximin or FODMAP restriction is going to reach the mechanism. P.P.S. — If your GI has mentioned a third colonoscopy or biologics for microscopic inflammation, you are being pushed toward invasive interventions for a mechanism no GI workup has tested for. Dissolve the shield first. Then decide what, if anything, you still need. P.P.P.S. — Claire: "Five years. Positive SIBO. Four rounds of rifaximin. Two scopes. Twelve-food safe list. 20 pounds of inflammation weight. $18,000. Nobody tested me for mold. Sixteen weeks on this protocol dissolved the shield and I hosted Thanksgiving for the first time in four years. Don't wait like I did."

thewellnessguide.com

The Gastroenterologist Broke Ranks😭💔

Dr. Rowan Kessler says after 26 years in GI, she finally questioned why recurrent SIBO kept returning after rifaximin and clean scopes.

Learn more: trycerise.com(opens in a new tab)

More from Rachel Smith

See all Rachel Smith ads

Similar ads in Fashion & Apparel

See all Fashion & Apparel ads